AlphaMark Advisors, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaMark Advisors, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$691,000
-9.9%
36,7480.0%0.36%
-7.8%
Q3 2016$767,000
+30.4%
36,748
+59.4%
0.39%
+11.5%
Q2 2016$588,000
-3.6%
23,0480.0%0.35%
+7.1%
Q1 2016$610,000
-53.1%
23,048
-24.1%
0.32%
-51.0%
Q4 2015$1,300,000
+123.0%
30,384
+38.1%
0.66%
+104.0%
Q3 2015$583,000
-20.5%
22,0000.0%0.32%
-21.4%
Q2 2015$733,00022,0000.41%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,546,180$30,460,0007.00%
Sio Capital Management, LLC 380,000$7,486,0003.56%
SCOPIA CAPITAL MANAGEMENT LP 7,223,906$142,311,0002.94%
RA Capital Management 900,259$17,735,0002.04%
Ghost Tree Capital, LLC 400,000$7,880,0001.64%
PFM Health Sciences, LP 2,588,157$50,987,0001.37%
Partner Investment Management, L.P. 47,752$941,0001.26%
Malaga Cove Capital, LLC 55,435$1,095,0000.66%
Spark Investment Management LLC 433,700$8,543,0000.53%
Alambic Investment Management, L.P. 217,610$4,287,0000.52%
View complete list of ACORDA THERAPEUTICS INC shareholders